Comgest Global Investors S.A.S. Novo Nordisk A S Transaction History
Comgest Global Investors S.A.S.
- $6.39 Billion
- Q2 2024
A detailed history of Comgest Global Investors S.A.S. transactions in Novo Nordisk A S stock. As of the latest transaction made, Comgest Global Investors S.A.S. holds 47,754 shares of NVO stock, worth $5.35 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
47,754
Previous 54,088
11.71%
Holding current value
$5.35 Million
Previous $6.94 Million
1.84%
% of portfolio
0.11%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,961Shares Held
320MCall Options Held
5.16MPut Options Held
4.96M-
Jennison Associates LLC21.2MShares$2.38 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.64 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.59 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.5 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.41 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $253B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...